Bank of Montreal’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.3M | Buy |
389,789
+91,986
| +31% | +$4.76M | 0.01% | 793 |
|
|
2026
Q1 | $15.1M | Sell |
297,803
-70,699
| -19% | -$3.3M | 0.01% | 948 |
|
|
2025
Q4 | $10.9M | Buy |
368,502
+24,636
| +7% | +$669K | ﹤0.01% | 1089 |
|
|
2025
Q3 | $8.88M | Buy |
343,866
+84,663
| +33% | +$2.36M | ﹤0.01% | 1092 |
|
|
2025
Q2 | $7.15M | Sell |
259,203
-30,834
| -11% | -$812K | ﹤0.01% | 1111 |
|
|
2025
Q1 | $8.22M | Sell |
290,037
-42,409
| -13% | -$1.5M | ﹤0.01% | 1009 |
|
|
2024
Q4 | $13.8M | Sell |
332,446
-93,614
| -22% | -$4.47M | 0.01% | 878 |
|
|
2024
Q3 | $28M | Sell |
426,060
-35,925
| -8% | -$3.3M | 0.01% | 656 |
|
|
2024
Q2 | $77.8M | Sell |
461,985
-26,125
| -5% | -$3.31M | 0.02% | 352 |
|
|
2024
Q1 | $54M | Sell |
488,110
-110,061
| -18% | -$11.1M | 0.02% | 427 |
|
|
2023
Q4 | $59.6M | Buy |
598,171
+186,741
| +45% | +$15.7M | 0.02% | 424 |
|
|
2023
Q3 | $47.2M | Sell |
411,430
-292,720
| -42% | -$32.7M | 0.02% | 439 |
|
|
2023
Q2 | $94.6M | Buy |
704,150
+381,082
| +118% | +$50.8M | 0.03% | 260 |
|
|
2023
Q1 | $49.7M | Sell |
323,068
-22,082
| -6% | -$3.64M | 0.02% | 383 |
|
|
2022
Q4 | $72.5M | Buy |
345,150
+80,400
| +30% | +$13.1M | 0.03% | 303 |
|
|
2022
Q3 | $37.6K | Sell |
264,750
-76,782
| -22% | -$11.7M | 0.02% | 456 |
|
|
2022
Q2 | $49.7K | Sell |
341,532
-565,101
| -62% | -$80.8M | 0.02% | 406 |
|
|
2022
Q1 | $164M | Sell |
906,633
-24,083
| -3% | -$4.05M | 0.08% | 183 |
|
|
2021
Q4 | $234M | Buy |
930,716
+351,116
| +61% | +$103M | 0.12% | 138 |
|
|
2021
Q3 | $225M | Buy |
579,600
+407,165
| +236% | +$150M | 0.1% | 170 |
|
|
2021
Q2 | $41M | Buy |
172,435
+50,557
| +41% | +$9.04M | 0.02% | 580 |
|
|
2021
Q1 | $16.3M | Sell |
121,878
-50,169
| -29% | -$7.27M | 0.01% | 766 |
|
|
2020
Q4 | $20.2M | Buy |
172,047
+15,886
| +10% | +$1.61M | 0.01% | 705 |
|
|
2020
Q3 | $11.1M | Buy |
156,161
+121,951
| +356% | +$8.5M | 0.01% | 814 |
|
|
2020
Q2 | $2.22M | Buy |
34,210
+27,986
| +450% | +$1.53M | ﹤0.01% | 1592 |
|
|
2020
Q1 | $206K | Sell |
6,224
-23,941
| -79% | -$551K | ﹤0.01% | 2314 |
|
|
2019
Q4 | $591K | Buy |
30,165
+528
| +2% | +$9.37K | ﹤0.01% | 2570 |
|
|
2019
Q3 | $472K | Buy |
29,637
+29,537
| +29,537% | +$436K | ﹤0.01% | 2448 |
|
|
2019
Q2 | $1K | Sell |
100
-1,560
| -94% | -$33.5K | ﹤0.01% | 4799 |
|
|
2019
Q1 | $34K | Buy |
+1,660
| New | +$30.8K | ﹤0.01% | 3494 |
|
Other funds holding MRNA
VCM
VPM
TP
Bank of Montreal's MRNA Position: Q2 2026 in Review
Bank of Montreal increased its Moderna (MRNA) stake by 31% in Q2 2026, buying an estimated $4.76M and bringing the position to 389,789 shares worth $27.3M. The position accounts for 0.01% of the portfolio, ranked #793.
Bank of Montreal first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $234M in Q4 2021. 730 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Bank of Montreal held 389,789 shares of Moderna worth $27.3M as of Q2 2026.
- Bank of Montreal bought 91,986 Moderna shares in Q2 2026, an estimated $4.76M.
- Moderna made up 0.01% of Bank of Montreal's portfolio in Q2 2026, its #793 holding.
- Bank of Montreal first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
- Bank of Montreal's Moderna position peaked at $234M in Q4 2021.
- 730 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.